Benzinga | Feb 25, 2021 08:41AM EST

Albireo Pharma Q4 EPS $(1.30) Beats $(1.94) Estimate, Sales $2.72M Beat $2.34M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(1.30) per share which beat the analyst consensus estimate of $(1.94) by 32.99 percent. This is a 128.07 percent decrease over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $2.72 million which beat the analyst consensus estimate of $2.34 million by 16.07 percent. This is a 57.77 percent decrease over sales of $6.43 million the same period last year.